Turn Therapeutics Inc. (TTRX)

Turn Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Capn/a
Revenue (ttm)n/a
Net Income (ttm)-2.56M
Shares Out n/a
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About TTRX

Turn Therapeutics is a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance. Our patented mixing process — commercially referred to as PermaFusion — enables stable suspension of polar, water-soluble active pharmaceutical ingredients (“APIs”) in oil-based carriers without the use of emulsifiers. This innovation reduces the quantity of required API inclusion by improving its bioavailability. Reduced API load reduces the likelihood of adverse events. Our proprieta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange NASDAQ
Ticker Symbol TTRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Wound and dermatology-focused Turn Therapeutics files for a direct listing on the Nasdaq

Turn Therapeutics, which is developing drugs and medical products for the wound and dermatology markets, filed on Tuesday to register its shares with the SEC and complete a direct listing on the Nasda...

5 days ago - Renaissance Capital

Turn Therapeutics IPO Registration Document (S-1)

Turn Therapeutics has filed to go public with an IPO on the NASDAQ.

8 days ago - SEC